SLC4 base (HCO3 -, CO3 2-) transporters: classification, function, structure, genetic diseases, and knockout models
1Division of Nephrology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 10833 Le Conte Avenue, Rm. 7-155 Factor Bldg., Los Angeles, CA 90095, USA.
This review discusses the role of SLC4 transporters in maintaining pH and base transport in mammalian cells. These proteins are crucial for regulating H+ and base levels in various tissues. Mutations in SLC4 genes are associated with disease in humans, and knockout models in mice show disrupted function. The study highlights recent findings on the molecular structure and physiological roles of SLC4 transporters. It also emphasizes their importance in kidney, pancreas, and eye function. The authors suggest that understanding SLC4 mechanisms could lead to new therapeutic strategies.
Area of Science:
- Membrane transport mechanisms in cell biology
- Genetic diseases in molecular medicine
- SLC4 transporter research in physiology
Background:
Regulation of pH is critical for cellular function, yet the mechanisms remain incompletely understood. Prior research has shown that H+ activity influences numerous biochemical and physiological processes. These processes require precise pH control to operate efficiently. Proteins have evolved to transport H+/base equivalents across membranes. This activity helps maintain intracellular and extracellular pH within specific ranges. The SLC4 family is known to mediate base transport in mammals. However, the full extent of their roles in disease remains unclear. This gap motivated a review of recent findings on SLC4 transporters.
Purpose Of The Study:
This review aims to summarize recent advances in SLC4 transporter biology. It addresses how these proteins contribute to pH regulation and base transport. The study explores their roles in kidney, pancreas, and eye function. It also examines the consequences of SLC4 mutations in human disease. Murine knockout models are analyzed to understand functional impacts. The goal is to clarify the molecular organization of SLC4 proteins. The study also highlights their role in disease pathogenesis. This synthesis provides a foundation for future research in this area.
Main Methods:
The researchers conducted a literature review on SLC4 transporters. They analyzed molecular organization and functional properties. They examined the role of SLC4 in pH regulation and base transport. The study included reviews of human genetic mutations. Murine knockout models were used to assess functional consequences. The researchers evaluated data from various organ systems. They focused on the kidney, pancreas, and eye. The approach combined biochemical, physiological, and genetic evidence.
Main Results:
SLC4 transporters mediate Na+ and Cl−-dependent base transport in mammals. These proteins are essential for pH regulation in multiple tissues. Mutations in SLC4 genes are linked to human disease phenotypes. Knockout models in mice show disrupted base transport. The transporters contribute to vectorial transepithelial base movement. Specific SLC4 members function in the kidney and pancreas. Genetic deletions lead to abnormal cellular pH regulation. These findings highlight the importance of SLC4 in physiological homeostasis.
Conclusions:
The review synthesizes evidence on SLC4 transporter function and disease. SLC4 proteins are essential for pH and base transport in mammals. Mutations in these genes lead to phenotypic abnormalities in humans. Knockout models confirm their role in cellular homeostasis. The study emphasizes the need for further research on SLC4 mechanisms. The findings support the importance of these transporters in organ function. The authors suggest that SLC4 research has clinical relevance. They propose that future studies should explore therapeutic implications.
Frequently Asked Questions
SLC4 transporters mediate Na+ and Cl−-dependent base transport, helping regulate pH in various tissues.
The kidney, pancreas, and eye are significantly impacted by SLC4 transporter dysfunction.
Knockout models help assess the functional consequences of SLC4 deletions in vivo.
It ensures directional movement of base across epithelial layers, crucial for organ function.
SLC4 mutations are linked to phenotypic abnormalities, including disrupted pH regulation.
The authors suggest exploring therapeutic implications of SLC4 transporter dysfunction.
More Related Videos
07:10High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies
Published on: September 29, 2023
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Related Concept Videos
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
ABC Transporters: Exporter
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
